Terms: = Pancreatic cancer AND PIM1, PIM, 5292, ENSG00000137193, P11309
46 results:
1. AUM302, a novel triple kinase pim/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor.
Ingle K; LaComb JF; Graves LM; Baines AT; Bialkowska AB
PLoS One; 2023; 18(11):e0294065. PubMed ID: 37943821
[TBL] [Abstract] [Full Text] [Related]
2. Subcellular localization of nucleolar protein 14 and its proliferative function mediated by miR-17-5p and E2F4 in pancreatic cancer.
Du YX; Zhou Y; Zheng XH; Duan YJ; Gu ZT; Yin YF; Wang CF
Aging (Albany NY); 2023 Jul; 15(14):7308-7323. PubMed ID: 37506248
[TBL] [Abstract] [Full Text] [Related]
3. Targeting macrophagic pim-1 alleviates osteoarthritis by inhibiting NLRP3 inflammasome activation via suppressing mitochondrial ROS/Cl
Zhang Z; Xie S; Qian J; Gao F; Jin W; Wang L; Yan L; Chen H; Yao W; Li M; Wang X; Zhu L
J Transl Med; 2023 Jul; 21(1):452. PubMed ID: 37422640
[TBL] [Abstract] [Full Text] [Related]
4. Topical advances in pim kinases and their inhibitors: Medicinal chemistry perspectives.
Walhekar V; Bagul C; Kumar D; Muthal A; Achaiah G; Kulkarni R
Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188725. PubMed ID: 35367531
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA RGMB-AS1 facilitates pancreatic cancer cell proliferation and migration but inhibits cell apoptosis via miR-574-3p/pim3 axis.
Song W; Shi C
Am J Physiol Gastrointest Liver Physiol; 2021 Nov; 321(5):G477-G488. PubMed ID: 34468207
[TBL] [Abstract] [Full Text] [Related]
6. Determining the Relative Gene Expression Level of Hypoxia Related Genes in Different cancer Cell Lines.
Baqlouq L; Zihlif M; Hammad H; Thaib TMA
Curr Mol Pharmacol; 2021; 14(1):52-59. PubMed ID: 32436837
[TBL] [Abstract] [Full Text] [Related]
7. DNA Methylation-Derived Immune Cell Profiles, CpG Markers of Inflammation, and pancreatic cancer Risk.
Michaud DS; Ruan M; Koestler DC; Alonso L; Molina-Montes E; Pei D; Marsit CJ; De Vivo I; Malats N; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1577-1585. PubMed ID: 32430337
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of Monitor-Image and Printout-Image Methods in Ki-67 Scoring of Gastroenteropancreatic Neuroendocrine Tumors.
Dogukan FM; Yilmaz Ozguven B; Dogukan R; Kabukcuoglu F
Endocr Pathol; 2019 Mar; 30(1):17-23. PubMed ID: 30367334
[TBL] [Abstract] [Full Text] [Related]
9. DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of pancreatic Ductal Adenocarcinoma Xenografts.
Wegner CS; Hauge A; Simonsen TG; Gaustad JV; Andersen LMK; Rofstad EK
Neoplasia; 2018 Jul; 20(7):734-744. PubMed ID: 29886124
[TBL] [Abstract] [Full Text] [Related]
10. The Theory and Practice of pancreatic Surgery in France.
Farges O; Bendersky N; Truant S; Delpero JR; Pruvot FR; Sauvanet A
Ann Surg; 2017 Nov; 266(5):797-804. PubMed ID: 28885506
[TBL] [Abstract] [Full Text] [Related]
11. MiR-377 inhibits the proliferation of pancreatic cancer by targeting pim-3.
Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
[TBL] [Abstract] [Full Text] [Related]
12. pim-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value.
Xu J; Xiong G; Cao Z; Huang H; Wang T; You L; Zhou L; Zheng L; Hu Y; Zhang T; Zhao Y
J Exp Clin Cancer Res; 2016 Sep; 35(1):133. PubMed ID: 27596051
[TBL] [Abstract] [Full Text] [Related]
13. pim-3 contributes to radioresistance through regulation of the cell cycle and DNA damage repair in pancreatic cancer cells.
Chen XY; Wang Z; Li B; Zhang YJ; Li YY
Biochem Biophys Res Commun; 2016 Apr; 473(1):296-302. PubMed ID: 27016481
[TBL] [Abstract] [Full Text] [Related]
14. Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer.
Wei ZR; Liang C; Feng D; Cheng YJ; Wang WM; Yang DJ; Wang YX; Cai QP
Oncotarget; 2016 Apr; 7(14):17737-50. PubMed ID: 26894969
[TBL] [Abstract] [Full Text] [Related]
15. Design and synthesis of an in vivo-efficacious pim3 kinase inhibitor as a candidate anti-pancreatic cancer agent.
Nakano H; Hasegawa T; Saito N; Furukawa K; Mukaida N; Kojima H; Okabe T; Nagano T
Bioorg Med Chem Lett; 2015 Dec; 25(24):5687-93. PubMed ID: 26547690
[TBL] [Abstract] [Full Text] [Related]
16. The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene pim1 in pancreatic cancer cells.
Blanco FF; Jimbo M; Wulfkuhle J; Gallagher I; Deng J; Enyenihi L; Meisner-Kober N; Londin E; Rigoutsos I; Sawicki JA; Risbud MV; Witkiewicz AK; McCue PA; Jiang W; Rui H; Yeo CJ; Petricoin E; Winter JM; Brody JR
Oncogene; 2016 May; 35(19):2529-41. PubMed ID: 26387536
[TBL] [Abstract] [Full Text] [Related]
17. MicroRNA‑506 participates in pancreatic cancer pathogenesis by targeting pim3.
Du J; Zheng X; Cai S; Zhu Z; Tan J; Hu B; Huang Z; Jiao H
Mol Med Rep; 2015 Oct; 12(4):5121-6. PubMed ID: 26238203
[TBL] [Abstract] [Full Text] [Related]
18. MicroRNA-33a-mediated downregulation of pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine.
Liang C; Yu XJ; Guo XZ; Sun MH; Wang Z; Song Y; Ni QX; Li HY; Mukaida N; Li YY
Oncotarget; 2015 Jun; 6(16):14440-55. PubMed ID: 25971209
[TBL] [Abstract] [Full Text] [Related]
19. Kaempferol enhances the suppressive function of Treg cells by inhibiting FOXP3 phosphorylation.
Lin F; Luo X; Tsun A; Li Z; Li D; Li B
Int Immunopharmacol; 2015 Oct; 28(2):859-65. PubMed ID: 25870037
[TBL] [Abstract] [Full Text] [Related]
20. Performance of K-ras mutation analysis plus endoscopic ultrasound-guided fine-needle aspiration for differentiating diagnosis of pancreatic solid mass: a meta-analysis.
Xu Y; Hu D; Zhu Q; Sun Y
Chin Med J (Engl); 2014; 127(18):3296-301. PubMed ID: 25266530
[TBL] [Abstract] [Full Text] [Related]
[Next]
